IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · IEX Real-Time Price · USD
33.72
-2.20 (-6.12%)
At close: Jul 2, 2024, 4:00 PM
33.91
+0.19 (0.56%)
After-hours: Jul 2, 2024, 6:54 PM EDT

IDEAYA Biosciences Revenue

IDEAYA Biosciences had revenue of $15.50M in the twelve months ending March 31, 2024, down -67.33% year-over-year. In the year 2023, IDEAYA Biosciences had annual revenue of $23.39M, a decrease of -54.08%.

Revenue (ttm)
$15.50M
Revenue Growth
-67.33%
P/S Ratio
164.61
Revenue / Employee
$125,032
Employees
124
Market Cap
2.55B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202323.39M-27.55M-54.08%
Dec 31, 202250.93M22.99M82.28%
Dec 31, 202127.94M8.40M43.01%
Dec 31, 202019.54M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 8.97B
agilon health 4.78B
Progyny 1.11B
ACADIA Pharmaceuticals 813.81M
Tandem Diabetes Care 770.01M
TG Therapeutics 289.33M
ADMA Biologics 283.18M
MorphoSys AG 264.75M
Revenue Rankings